NOR Expression increases in interphase lymphocytes of Down syndrome babies/children as AgNORs surface, according to the mitogen concentration in the culture medium

Micron

Volumn 37, Issue 2, 2006, Pages 129-133

  Imamoglu, Nalan ^a   Demirtas, Halil ^a   Ilten, Ali ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Down syndrome; In vitro AgNORs, rRNA, rDNA; Phytohemagglutinin

Indexed keywords

DNA; GENES; IMAGE ANALYSIS; MICROORGANISMS; RNA;

DOWN SYNDROME; METAPHASE CELLS; PHYTOHEMAGGLUTININ (PHA);

CELL CULTURE;

CELL NUCLEUS ANTIGEN; MITOGENIC AGENT; NUCLEAR PROTEIN; NUCLEOLAR ORGANIZER REGION ASSOCIATED PROTEINS; PHYTOHEMAGGLUTININ;

ARTICLE; BLOOD; CELL CULTURE; CHILD; CHROMOSOME NOR; DOWN SYNDROME; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMAGE PROCESSING; INFANT; INTERPHASE; LYMPHOCYTE; METABOLISM; NEWBORN; PHYSIOLOGY; PRESCHOOL CHILD; RNA GENE; STAINING;

ANTIGENS, NUCLEAR; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; GENE EXPRESSION REGULATION; GENES, RRNA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFANT; INFANT, NEWBORN; INTERPHASE; LYMPHOCYTES; MITOGENS; NUCLEAR PROTEINS; NUCLEOLUS ORGANIZER REGION; PHYTOHEMAGGLUTININS; STAINING AND LABELING;

EID: 30144441189     PISSN: 09684328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micron.2005.09.002     Document Type: Article

References (23)

1. S.E. Antonarakis, R. Lyle, R. Chrast, and H.S. Scott Differential gene expression studies to explore the molecular pathophysiology of Down syndrome Brain Res. Rev. 36 2001 265 274
2. P.A. Benn, and M.A. Perle D.E. Rooney B.H. Czepulkowski Chromosome Staining and Banding Techniques Human Cytogenetics, Constitutional Analysis, A practical approach vol. I 1992 Oxford University Press Oxford 91 118
3. B. Borsatto, and M.A.C. Smith Reduction of the activity of ribosomal genes with age in Down's syndrome Gerontology 42 1996 147 154
4. A. Capoa, M.P. Felli, A. Baldini, M. Rocchi, N. Archidiacono, C. Aleixandre, O.J. Miller, and D.A. Miller Relationship between the number and function of human ribosomal genes Hum. Genet. 79 1988 301 304
5. M.S. Cheon, K.S. Shim, S.H. Kim, A. Hara, and G. Lubec Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: Challenging the gene dosage effect hypothesis (Part IV) Amino Acids 25 2003 41 47
6. H. Demirtas, N. Imamoglu, N. Cucer, H. Donmez, A. Yilmaz, Z. Candemir, and I. Bokesoy NOR (rDNA) expression enhancement in phytohemagglutinin- stimulated lymphocytes of Down syndrome patients Erciyes University J. Health Sci. 8 1999 24 27
7. H. Demirtas, Z. Candemir, N. Cucer, N. Imamoglu, H. Donmez, and I. Bokesoy Essay on the nucleoli survey by the α- and β-satellite DNA probes of the acrocentric chromosome in mitogen-stimulated human lymphocytes Ann. Génét-Paris 43 2000 61 68
8. H. Demirtas, N. Imamoglu, H. Donmez, N. Cucer, A. Yilmaz, and Z. Candemir Condensed chromatin surface and NOR surface enhancement in mitogen-stimulated lymphocytes of Down syndrome patients Ann. Génét-Paris 44 2001 77 82
9. M. Derenzini, F. Farabegoli, A. Pession, and F. Novello Spatial redistribution of ribosomal chromatin in the fibrillar centres of human circulating lymphocytes after stimulation of transcription Exp. Cell Res. 170 1987 31 41
10. R. Ferrando-Miguel, M.S. Cheon, and G. Lubec Protein levels of genes encoded on chromosome 21 in fetal Down Syndrome brain (Part V): overexpression of phosphatidyl-inositol-glycan class P protein (DSCR5) Amino Acids 26 2004 255 261
11. K. Gardiner, A. Fortna, L. Bechtel, and M.T. Davisson Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions Gene 318 2003 137 147
12. S. Greber-Platzer, D. Schatzmann-Turhani, G. Wollenek, and G. Lubec Evidence against the current hypothesis of gene dosage effects of Trisomy 21: ets-2, encoded on chromosome 21 is not overexpressed in hearts of patients with Down syndrome Biochem. Biophys. Res. Commun. 254 1999 395 399
13. J.E. Green, K.N. Rosenbaum, S.I. Rapoport, M.B. Schapiro, and B.J. White Variant nucleolus organizing regions and the risk of Down syndrome Clin. Genet. 35 1989 243 250
14. C. Harris-Cerruti, A. Kamsler, B. Kaplan, B. Lamb, M. Segal, and Y. Groner Functional and morphological alterations in compound transgenic mice overexpressing Cu/Zn superoxide dismutase and amyloid precursor protein Eur. J. Neurosci. 19 2004 1174 1190
15. D. Hernandez-Verdun, and E. Louvet Le nucleole: fonctions et maladies associées Med. Sci. (Paris) 20 2004 37 44
16. H.R. Hubbell Silver staining as an indicator of active ribosomal genes Stain Technol. 60 1985 285 294
17. N. Imamoglu, H. Demirtas, H. Donmez-Altuntas, Z. Hamurcu, and A. Ilten NORs Expression increases on metaphase chromosomes of Down syndrome lymphocytes, in concordance with the mitogen concentration in the culture medium Cytometry Part B-Clin Cytom. 66B 2005 36 39
18. N. Imamoglu, H. Demirtas, H. Donmez-Altuntas, and A. Ilten Higher NORs expression in lymphocyte of trisomy 21 babies/children: in vivo evaluation Micron 36 2005 503 507
19. R. Jimènez, and M. Burgos A study of the Ag-staining significance in mitotic NOR's Heredity 60 1988 125 127
20. L.E. Lindner Improvements in the silver-staining technique for Nucleolar Organizer Regions (Ag-NOR) J. Histochem. Cytochem. 41 1993 439 445
21. K.S. Shim, J.M. Bergelson, M. Furuse, V. Ovod, T. Krude, and G. Lubec Reduction of chromatin assembly factor 1 p60 and C21orf2 protein, encoded on chromosome 21, in Down syndrome brain J. Neural Transm. Suppl. 67 2003 117 128
22. A.T. Sumner Nucleolar organizers A.T. Sumner Chromosome Banding 1990 Unwin Hyman London 187 205
23. D. Trerè AgNOR staining and quantification Micron 31 2000 127 131